As the use of GLP-1 medications rises in the United States and the United Kingdom, those undergoing treatment report changes not only in their bodies but also in their personal relationships. GLP-1s, drugs that aid in weight loss by curbing appetite and influencing metabolism, are reshaping dynamics between users and their partners, family, and friends.
Dr. Lindsey Berisha, a licensed clinical psychologist with over a decade of experience working with GLP-1 users, explains that relationships typically settle into patterns of equilibrium and predictability. Significant changes in one partner’s health or appearance can disrupt this balance, prompting uncertainty even if the changes are viewed positively. Berisha notes that patients often experience relief from obsessive food thoughts and develop greater self-compassion as they come to understand their prior struggles with weight as medically based, rather than a result of personal failure. “This shift can often be more impactful than the weight loss itself,” she says.
However, reactions from those close to GLP-1 users vary widely. Dr. Rachel Goldman, another clinical psychologist, highlights that family and friends may respond with support or, conversely, with feelings of insecurity or concern about how the relationship might evolve. She stresses the importance of open communication as a means of navigating these transitions.
Reflecting these complexities, 11 individuals shared their experiences with GLP-1 medications and the effects on their relationships. A woman whose husband is skeptical about the drug’s safety described feeling isolated, unable to share her positive experiences with someone she trusted. She emphasized her lifelong battle with obesity and the frustration of her husband’s dismissive viewpoint, which he saw as a failure of willpower rather than a chronic medical condition.
Another user recounted how her 20-year-old daughter’s discovery of her GLP-1 treatment sparked feelings of worry and jealousy, given the central role food played in their family life. Although she appreciated the physical benefits of weight loss, she also grappled with feelings of guilt and the fear she was seen as taking a shortcut.
Some partners of GLP-1 users reported mixed emotions, including envy or a sense of loss. One individual expressed that sharing meals with a partner on the medication made him feel greedy and envious, though he recognized the drug’s value. Others described strained friendships due to the frequent focus on weight and diet conversations, while some shared minimal impact on their relationships, highlighting increased openness and presence due to symptom relief from disordered eating.
Several users emphasized the stigma still associated with using GLP-1s. One individual who had maintained significant weight loss in secret worried that disclosing medication use might invite judgment or imply a lack of effort. Another reported improved self-confidence and relationship prospects after losing weight but had not yet disclosed the treatment to new partners.
Not all accounts were positive. A man described his ex-wife’s use of the drug that led to her substantial weight loss but ultimately coincided with the end of their marriage. Another noted negative emotional changes in his wife after beginning GLP-1 treatment, expressing concern over her diminished appetite and motivation.
In contrast, a user from the UK described a supportive partner who embraced lifestyle changes alongside her after she began using Mounjaro, another GLP-1 drug. Their shared efforts in exercise and healthier habits have strengthened their relationship, demonstrating the potential for positive outcomes when support systems are engaged.
As GLP-1 medications continue to be widely adopted, these varied personal perspectives highlight the nuanced ways such treatments intersect with human connections. Experts underscore the importance of communication and mutual understanding as users and their loved ones navigate the transformations prompted by these medications.